fig2
From: Efficacy of ICIs on patients with oncogene-driven non-small cell lung cancer: a retrospective study
![Efficacy of ICIs on patients with oncogene-driven non-small cell lung cancer: a retrospective study](https://image.oaes.cc/f7873f0b-474a-4698-955a-9dcff4ba4167/4459.fig.2.jpg)
Figure 2. Categorical distribution of tumor PD-L1 expression: the whole cohort (A); EGFR-mutant NSCLC tumors (B); KRAS-mutant NSCLC tumors (C); and HER2-mutant NSCLC tumors (D). EGFR: Epidermal growth factor receptor; NSCLC: non-small-cell lung cancer; KRAS: V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog; HER2: human epidermal growth factor receptor 2.